We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
351
DELISTED
Activision Blizzard
ATVI
$251M 0.05%
6,343,373
+3,221,779
+103% +$118M
MMM icon
352
3M
MMM
$94.4B
$251M 0.05%
1,714,832
+10,629
+0.6% +$1.5M
AKR icon
353
Acadia Realty Trust
AKR
$2.83B
$249M 0.05%
7,004,450
-173,169
-2% -$5.92M
CPT icon
354
Camden Property Trust
CPT
$10.9B
$249M 0.05%
2,811,381
+114,920
+4% +$9.59M
UE icon
355
Urban Edge Properties
UE
$2.73B
$248M 0.05%
8,311,622
+159,240
+2% +$4.27M
TMX
356
DELISTED
Terminix Global Holdings, Inc.
TMX
$247M 0.05%
9,254,852
-4,546,468
-33% -$116M
AMT.PRB
357
DELISTED
American Tower Corporation
AMT.PRB
$246M 0.05%
+2,223,765
New +$235M
AMG icon
358
Affiliated Managers Group
AMG
$9.48B
$244M 0.05%
1,732,090
-409,593
-19% -$67M
WAL icon
359
Western Alliance Bancorporation
WAL
$8.89B
$242M 0.05%
7,414,264
+120,713
+2% +$4.24M
VMI icon
360
Valmont Industries
VMI
$9.52B
$240M 0.05%
1,777,012
-43,098
-2% -$5.7M
VIAB
361
DELISTED
Viacom Inc. Class B
VIAB
$240M 0.05%
5,780,495
+865,540
+18% +$35.8M
RTN
362
DELISTED
Raytheon Company
RTN
$239M 0.05%
1,757,128
+364,716
+26% +$47.5M
CMG icon
363
Chipotle Mexican Grill
CMG
$40.5B
$238M 0.05%
29,548,100
-7,045,450
-19% -$61.3M
FANG icon
364
Diamondback Energy
FANG
$56.5B
$238M 0.05%
2,608,281
-243,948
-9% -$21.1M
ZG icon
365
Zillow
ZG
$7.71B
$236M 0.05%
6,451,806
-980,825
-13% -$27.8M
KRC icon
366
Kilroy Realty
KRC
$4.24B
$236M 0.05%
3,560,370
-79,480
-2% -$5.03M
ALGT icon
367
Allegiant Air
ALGT
$2.42B
$236M 0.05%
1,557,580
+36,511
+2% +$5.63M
CNA icon
368
CNA Financial
CNA
$13.8B
$234M 0.05%
7,448,005
+363,460
+5% +$11.6M
CGNX icon
369
Cognex
CGNX
$10.6B
$234M 0.05%
10,847,260
-448,646
-4% -$9.04M
CAH icon
370
Cardinal Health
CAH
$55.9B
$232M 0.05%
2,972,154
-2,343,773
-44% -$187M
SPGI icon
371
S&P Global
SPGI
$120B
$232M 0.05%
+2,159,108
New +$232M
RBC icon
372
RBC Bearings
RBC
$17.5B
$232M 0.05%
3,193,701
-9,460
-0.3% -$694K
ACAD icon
373
Acadia Pharmaceuticals
ACAD
$5.07B
$231M 0.05%
7,115,279
-875,038
-11% -$29.3M
DD icon
374
DuPont de Nemours
DD
$19.5B
$230M 0.05%
1,828,475
+877,877
+92% +$115M
DATA
375
DELISTED
Tableau Software, Inc.
DATA
$229M 0.05%
4,689,813
+4,670,611
+24,324% +$234M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.